Scandmedical Soldk 040 Stock Current Valuation
| K41 Stock | 0.70 0.01 1.41% |
Valuation analysis of SCANDMEDICAL SOLDK 040 helps investors to measure SCANDMEDICAL SOLDK-040's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns.
Overvalued
Today
Please note that SCANDMEDICAL SOLDK-040's price fluctuation is dangerous at this time. Calculation of the real value of SCANDMEDICAL SOLDK 040 is based on 3 months time horizon. Increasing SCANDMEDICAL SOLDK-040's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the SCANDMEDICAL stock is determined by what a typical buyer is willing to pay for full or partial control of SCANDMEDICAL SOLDK 040. Since SCANDMEDICAL SOLDK-040 is currently traded on the exchange, buyers and sellers on that exchange determine the market value of SCANDMEDICAL Stock. However, SCANDMEDICAL SOLDK-040's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.7 | Real 0.61 | Hype 0.7 | Naive 0.7 |
The real value of SCANDMEDICAL Stock, also known as its intrinsic value, is the underlying worth of SCANDMEDICAL SOLDK 040 Company, which is reflected in its stock price. It is based on SCANDMEDICAL SOLDK-040's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of SCANDMEDICAL SOLDK-040's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of SCANDMEDICAL SOLDK 040 helps investors to forecast how SCANDMEDICAL stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of SCANDMEDICAL SOLDK-040 more accurately as focusing exclusively on SCANDMEDICAL SOLDK-040's fundamentals will not take into account other important factors: SCANDMEDICAL SOLDK 040 Company Current Valuation Analysis
SCANDMEDICAL SOLDK-040's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, SCANDMEDICAL SOLDK 040 has a Current Valuation of 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Medical Devices industry. The current valuation for all Germany stocks is 100.0% higher than that of the company.
SCANDMEDICAL Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses SCANDMEDICAL SOLDK-040's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of SCANDMEDICAL SOLDK-040 could also be used in its relative valuation, which is a method of valuing SCANDMEDICAL SOLDK-040 by comparing valuation metrics of similar companies.SCANDMEDICAL SOLDK is currently under evaluation in current valuation category among its peers.
About SCANDMEDICAL SOLDK-040 Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze SCANDMEDICAL SOLDK 040's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of SCANDMEDICAL SOLDK-040 using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of SCANDMEDICAL SOLDK 040 based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in SCANDMEDICAL Stock
SCANDMEDICAL SOLDK-040 financial ratios help investors to determine whether SCANDMEDICAL Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in SCANDMEDICAL with respect to the benefits of owning SCANDMEDICAL SOLDK-040 security.